Bio-Techne Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TECH | CAI | TWST | MRVI | DNA | FTRE | |
|---|---|---|---|---|---|---|
| Market cap | 11.38B | 8.39B | 10.07B | 2.61B | 793.94M | 2.00B |
| P/E (TTM) | 62.6 | 17.6 | — | — | — | — |
| Forward P/E | 31.4 | 80.4 | -379.7 | -70.1 | -4.1 | 18.6 |
| Price/book | 5.4 | 14.2 | 21.4 | 5.1 | 1.8 | 3.8 |
| Dividend yield | 0.44% | — | — | — | — | — |
| 1-year change | +21.48% | −1.85% | +430.13% | +125.45% | −1.22% | +112.22% |
| Today | +0.14% | −0.03% | −4.96% | −5.11% | −9.31% | +0.77% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All TECH news ›Bio-Techne opens GMP small molecule facility in Bristol, UK
Life science tools and diagnostics provider Bio-Techne Corporation has opened a new manufacturing facility in Bristol, UK, dedicated to good manufacturing practice (GMP) grade small molecules. The purpose-built 10,000ft² site is fully…
Bio-Techne opens GMP manufacturing facility in Bristol to support cell therapy development
The facility strengthens the firm's advanced therapy supply chain, complementing its manufacturing plants in the US. According to the firm, the expansion strengthens Bio-Techne’s network alongside its recombinant protein manufacturing…
Bio-Techne expands global GMP manufacturing network with new Bristol facility to advance scalable cell therapy development
Bio-Techne Corporation, a global provider of life science tools, reagents and diagnostic products, today announced the opening of a new manufacturing facility for Good Manufacturing Practice (GMP) grade small molecules in Bristol, United…
NASDAQ listed Bio-Techne hails South West's fast-growing life sciences sector as it opens Bristol cell therapy facility
Site manufactures molecules to treat conditions including type 1 diabetes and Parkinson's NASDAQ listed Bio-Techne hails South West’s fast-growing life sciences sector as it opens Bristol cell therapy facility More from South West -…
Performance Days put bio-based materials centre stage in Munich
FashionNetwork India Performance Days is about to get underway With its upcoming â and largest to date â edition on October 13 and 14, the Munich trade fair for functional textiles will shine a spotlight on one of the most significant…
Bio-Techne Corp Stock 12‑Month Price Target Raised to $73.22, Implies 1% Upside
TradingView Bio-Techne Corp Stock 12‑Month Price Target Raised to $73.22, Implies 1% Upside - According to estimates from 9 analysts, Bio-Techne Corp stock's average price target has risen from $70.9 to $73.22, with forecasts ranging from…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com2
-
bioprocessintl.com1
-
businessnewsthisweek.com1
-
contractpharma.com1
-
gurufocus.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.